Galecteye Pharma ApS: Financial statements 2018
CVR: 38248243
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Galecteye Pharma ApS (CVR 38248243) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -10,040 and a net result of DKK -11,050 compared with DKK -18,153 the year before. Equity in the 2018 report amounted to DKK 20,797. The solvency ratio was 16%.
- Gross Profit
- DKK -10,040
- Profit/Loss
- DKK -11,050
- Equity
- DKK 20,797
- Total Assets
- DKK 130,349
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -10 t. | -11 t. | 21 t. | - |
| 2017 | - | -17 t. | -18 t. | 32 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Galecteye Pharma ApS has published its annual report for 2017. Gross profit came to DKK -17,105, and the net result was DKK -18,153.
As of May 15, 2018, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Galecteye Pharma ApS.
About Galecteye Pharma ApS
Galecteye Pharma ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2016 and dissolved in 2022. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2020, the company reported a gross profit of DKK -6,250 and a net result of DKK -7,280 compared with DKK -6,020 the year before. Equity in the 2020 report amounted to DKK 7,497.